|
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News
|
Rebecca Zacks |
05/07/08 |
|
No Comments
|
|
Let the Epic Curing Begin: Epix and Curis Earn Milestone Payments
|
Erik Mellgren |
05/05/08 |
|
No Comments
|
|
Mascoma Teams with GM, Moldflow Melds with Autodesk, Concert Scores Some Heavy-Duty Cash, & More Deals News
|
Rebecca Zacks |
05/05/08 |
|
No Comments
|
|
Three Luminaries, Two Third Revolutions, and One Nice Suit: An Xconomy Forum on the Future of Life Sciences in New England
|
Rebecca Zacks |
05/02/08 |
|
No Comments
|
|
GM Chips In for Mascoma’s Cellulosic Biofuel Technology
|
Wade Roush |
05/02/08 |
|
No Comments
|
|
Heavyweight Hydrogen Takes $37 Million Prize for Concert Pharmaceuticals
|
Erik Mellgren |
05/01/08 |
|
No Comments
|
|
InfraReDx Gets FDA Nod for Artery-Imaging Tool
|
Rebecca Zacks |
04/30/08 |
|
No Comments
|
|
ZS Genetics Enters the X Prize Fray, Biogen Falls on Rituxan News, Acusphere Takes a Step Toward Clinical Finish Line, & More Life Sciences News
|
Rebecca Zacks |
04/30/08 |
|
No Comments
|
|
Retail Convergence Meets Up With Some Cash, TheStreet Takes to Geezeo, GSK Lifts a Glass to Sirtris, & More Deals News
|
Rebecca Zacks |
04/28/08 |
|
No Comments
|
|
GSK Takes Sirtris and Taps Alnylam Venture, FDA Deals Genzyme Drug a Blow, Resolvyx Finances Fish-Oil Drugs, & More Life Sciences News
|
Rebecca Zacks |
04/23/08 |
|
No Comments
|
|
With a $25 Million Bankroll and Technology “Fully Baked” by Biogen Idec, Stromedix is Heading into the Uncharted Territory of Fibrosis
|
Rebecca Zacks |
04/21/08 |
|
No Comments
|
|
Alnylam Joint Venture Regulus Inks Deal with GSK Worth up to $600 Million
|
Erik Mellgren |
04/17/08 |
|
No Comments
|
|
$50 Million Serono Expansion to Create 100 New Massachusetts Jobs
|
Erik Mellgren |
04/16/08 |
|
No Comments
|
|
A Lawsuit for Biogen, A Suitor for Millennium, The Suits Who Made Their Own Fate, & More Life Sciences News
|
Rebecca Zacks |
04/16/08 |
|
No Comments
|
|
Entrepreneurs at Three Massachusetts Colleges Rake in the Prize Money
|
Rebecca Zacks |
04/15/08 |
|
2 Comments
|
|
Life Sciences 2028—Three Snapshots of the Future
|
Robert Buderi |
04/14/08 |
|
No Comments
|
|
Millennium Makes a Surprise Exit, EMC’s Persistence Pays Off, Quantum Dots a Vision to In-Q-Tel, & More Deals News
|
Rebecca Zacks |
04/14/08 |
|
No Comments
|
|
Diomed to Sell Assets to AngioDynamics for $11M
|
Rebecca Zacks |
04/11/08 |
|
No Comments
|
|
Patent Reform Blocked, Epix Deal Expanded, Repligen Suit Settled, & More Life Sciences News
|
Rebecca Zacks |
04/09/08 |
|
No Comments
|
|
Repligen, BMS Settle Patent Suit
|
Rebecca Zacks |
04/08/08 |
|
No Comments
|
|
In Latest Local Venture Philanthropy Deal, Cystic Fibrosis Foundation Pledges up to $37.7 More to Epix
|
Rebecca Zacks |
04/07/08 |
|
No Comments
|
|
EMC Tangos with Conchango, MIT Media Lab Goes to the Bank, GT Solar Makes European Inroads, & More Deals News
|
Rebecca Zacks |
04/07/08 |
|
No Comments
|
|
Vertex on the Rise, Sirtris on TV, an IPO (Finally) on the Table, and More Life Sciences News
|
Rebecca Zacks |
04/02/08 |
|
No Comments
|
|
BioTrove Seeks Big Trove in IPO
|
Rebecca Zacks |
04/01/08 |
|
No Comments
|
|
1366’s Sunny Start, Adimab’s Second Round, Constant Contact’s Second Offering, and More Deals News
|
Rebecca Zacks |
03/31/08 |
|
No Comments
|
|
UMass Doles out $240,000 to Turn Research Ideas into Commercial Products
|
Neil Savage |
03/27/08 |
|
No Comments
|
|
Vertex Climbs on Encouraging Early Results From Cystic Fibrosis Drug Trial
|
Rebecca Zacks |
03/27/08 |
|
No Comments
|
|
Alkermes Makes Cuts, Eyegate Avoids Pokes, Codon Gets a Boost, & More Life Sciences News
|
Rebecca Zacks |
03/26/08 |
|
No Comments
|
|
Adimab Scores Second Funding Round in Less Than A Year
|
Rebecca Zacks |
03/25/08 |
|
No Comments
|
|
EyeGate Pharma Sees a New Way of Delivering Drugs to the Eye
|
Neil Savage |
03/20/08 |
|
No Comments
|
